Magnesium Glycinate Muscle Recovery Randomized Trial: What the Evidence Says

Quick Answer

Magnesium Glycinate Muscle Recovery Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Accumulating evidence indicates that magnesium regulates bone metabolism through multiple signaling pathways, including PI3K/Akt, OPG/RANKL/RANK, TRPM, etc. [Sheng Shaoying (2026); evidence level 3]
• Dysregulated magnesium metabolism has been associated with osteoporosis, impaired fracture healing, and other skeletal disorders. [Sheng Shaoying (2026); evidence level 3]
• Adequate magnesium status supports muscle contraction and relaxation, regulates electrolyte balance, and enhances exercise capacity as well as post-exercise recovery, whereas deficiency is associated with fatigue, weakness, and impaired physical performance. [Matek Sarić Marijana (2025); evidence level 3]
• Growing evidence links insufficient intake to hypertension, type 2 diabetes, osteoporosis, migraines, depression, and chronic inflammation. [Matek Sarić Marijana (2025); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For magnesium glycinate muscle recovery randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Sheng Shaoying (2026). Application and translational research of magnesium in nursing care of orthopedic diseases: from mechanism to clinical translation. DOI: 10.3389/fchem.2026.1817443. PMCID: PMC13133653. PMID: 42079869. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13133653/
• Matek Sarić Marijana (2025). Magnesium: Health Effects, Deficiency Burden, and Future Public Health Directions. DOI: 10.3390/nu17223626. PMCID: PMC12655508. PMID: 41305676. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12655508/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.